FOXO1 and mantle cell lymphoma: These findings identify FOXO1 as a master regulator for MCL lineage survival and highlight pharmacological FOXO1 inhibition as a therapeutic strategy targeting lineage-driven transcriptional addiction in MCL (Figure 7F).